2q31 microdeletion syndrome with the velocardiofacial phenotype and review of the literature: a case report.
2q31-q32 microdeletion
Array CGH
Facial dysmorphism
Velocardiofacial syndrome
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
09 Oct 2024
09 Oct 2024
Historique:
received:
30
11
2022
accepted:
17
05
2024
medline:
10
10
2024
pubmed:
10
10
2024
entrez:
9
10
2024
Statut:
epublish
Résumé
The 2q31 deletion results in a distinct phenotype characterized by varying degrees of developmental delay, short stature, facial dysmorphism, and variable limb defects. Dysmorphic features include microcephaly, downslanting palpebral fissures, a long and flat philtrum, micrognathia, and dysplastic, low-set ears. To date, comparative genomic hybridization has identified this deletion in 38 patients. Consequently, additional patients with comprehensive clinical data are required to fully understand the spectrum of clinical manifestation associated with a deletion in the 2q31 cytoband. We present the case of an 8-year-old female patient with clinical features of velocardiofacial syndrome, which include facial dysmorphism, congenital heart disease (persistent truncus arteriosus and ostium secundum-type atrial septal defect), and a seizure syndrome. Array comparative genomic hybridization revealed a non-continous deletion spanning cytobands 2q31.1-to 2q31.3, confirming a diagnosis of 2q31 microdeletion syndrome. The patient has undergone supportive therapies for swallowing and speech. Additionally, we provide a review of the literature on previous cases to give context. In this report, we present the first documented case of a complex, discontinuous deletion spanning in the 2q31-2q32 regions. This case contributes to our understanding of the phenotypic and mutational spectrum observed in individuals with deletions in these cytobands. It underscores the significance of employing high-resolution techniques and comprenhensive analysis in diagnosing patients with complex phenotypes. Such approaches are crucial for differentiating this condition from more common microdeletion syndromes, such as the 22q11 deletion syndrome.
Sections du résumé
BACKGROUND
BACKGROUND
The 2q31 deletion results in a distinct phenotype characterized by varying degrees of developmental delay, short stature, facial dysmorphism, and variable limb defects. Dysmorphic features include microcephaly, downslanting palpebral fissures, a long and flat philtrum, micrognathia, and dysplastic, low-set ears. To date, comparative genomic hybridization has identified this deletion in 38 patients. Consequently, additional patients with comprehensive clinical data are required to fully understand the spectrum of clinical manifestation associated with a deletion in the 2q31 cytoband.
CASE PRESENTATION
METHODS
We present the case of an 8-year-old female patient with clinical features of velocardiofacial syndrome, which include facial dysmorphism, congenital heart disease (persistent truncus arteriosus and ostium secundum-type atrial septal defect), and a seizure syndrome. Array comparative genomic hybridization revealed a non-continous deletion spanning cytobands 2q31.1-to 2q31.3, confirming a diagnosis of 2q31 microdeletion syndrome. The patient has undergone supportive therapies for swallowing and speech. Additionally, we provide a review of the literature on previous cases to give context.
CONCLUSION
CONCLUSIONS
In this report, we present the first documented case of a complex, discontinuous deletion spanning in the 2q31-2q32 regions. This case contributes to our understanding of the phenotypic and mutational spectrum observed in individuals with deletions in these cytobands. It underscores the significance of employing high-resolution techniques and comprenhensive analysis in diagnosing patients with complex phenotypes. Such approaches are crucial for differentiating this condition from more common microdeletion syndromes, such as the 22q11 deletion syndrome.
Identifiants
pubmed: 39385145
doi: 10.1186/s12887-024-04843-7
pii: 10.1186/s12887-024-04843-7
doi:
Types de publication
Journal Article
Case Reports
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
641Informations de copyright
© 2024. The Author(s).
Références
Mencarelli MA, Caselli R, Pescucci C, Hayek G, Zappella M, Renieri A, et al. Clinical and molecular characterization of a patient with a 2q31.2-32.3 deletion identified by Array-CGH. Am J Med Genet Part A. 2007;143A:858–65.
doi: 10.1002/ajmg.a.31602
pubmed: 17352388
Theisen A, Rosenfeld JA, Shane K, McBride KL, Atkin JF, Gaba C, et al. Refinement of the region for split hand/foot malformation 5 on 2q31.1. Mol Syndromol. 2011;1:262–71.
doi: 10.1159/000328405
pmcid: 3214950
Dimitrov B, Balikova I, De Ravel T, Van Esch H, De Smedt M, Baten E, et al. 2q31.1 Microdeletion syndrome: redefining the associated clinical phenotype. J Med Genet. 2011;48:98–104.
doi: 10.1136/jmg.2010.079491
pubmed: 21068127
Mitter D, Delle Chiaie B, Lüdecke HJ, Gillessen-Kaesbach G, Bohring A, Kohlhase J, et al. Genotype-phenotype correlation in eight new patients with a deletion encompassing 2q31.1. Am J Med Genet Part A. 2010;152:1213–24.
doi: 10.1002/ajmg.a.33344
Okamoto N, Kimura S, Shimojima K, Yamamoto T. Neurological manifestations of 2q31 microdeletion syndrome. Congenit Anom (Kyoto). 2017;57:197–200.
doi: 10.1111/cga.12212
pubmed: 28145600
Tsai LP, Liao HM, Chen YJ, Fang JS, Chen CH. A novel microdeletion at chromosome 2q31.1-31.2 in a three-generation family presenting duplication of great toes with clinodactyly. Clin Genet. 2009;75:449–56.
doi: 10.1111/j.1399-0004.2008.01147.x
pubmed: 19459884
Svensson A, Curry C, South ST, Whitby H, Maxwell T, Aston E, et al. Detection of a de novo interstitial 2q microdeletion by CGH Microarray Analysis in a patient with limb malformations, Microcephaly and Mental Retardation. Am J Med Genet Part A. 2007;143A:1348–53.
doi: 10.1002/ajmg.a.31775
pubmed: 17506097
Ferreira SI, Matoso E, Venncio M, Saraiva J, Melo JB, Carreira IM. Critical region in 2q31.2q32.3 deletion syndrome: report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region. Mol Cytogenet. 2012;5:1–7.
doi: 10.1186/1755-8166-5-25
Wang T, Mao J, Liu MJ, Choy KW, Li HB, Cram DS, et al. A patient with five chromosomal rearrangements and a 2q31.1 microdeletion. Clin Chim Acta. 2014;430:129–33.
doi: 10.1016/j.cca.2014.01.002
pubmed: 24412318
Puvabanditsin S, February M, Shaik T, Kashyap A, Bruno C, Mehta R. 2Q31.1 Microdeletion Syndrome: Case Report and Literature Review. Clin Case Rep. 2015;3:357–60.
doi: 10.1002/ccr3.260
pubmed: 26185628
pmcid: 4498842
Monfort S, Roselló M, Orellana C, Oltra S, Blesa D, Kok K, et al. Detection of known and novel genomic rearrangements by array based comparative genomic hybridisation: deletion of ZNF533 and duplication of CHARGE syndrome genes. J Med Genet. 2008;45:432–7.
doi: 10.1136/jmg.2008.057596
pubmed: 18413373
Rifai L, Port-Lis M, Tabet AC, Bailleul-Forestier I, Benzacken B, Drunat S, et al. Ectodermal dysplasia-like syndrome with mental retardation due to contiguous gene deletion: further clinical and molecular delineation of Del(2q32) syndrome. Am J Med Genet Part A. 2010;152:111–7.
doi: 10.1002/ajmg.a.33164
Prontera P, Bernardini L, Stangoni G, Capalbo A, Rogaia D, Ardisia C, et al. 2q31.2q32.3 deletion syndrome: report of an adult patient. Am J Med Genet Part A. 2009;149:706–12.
doi: 10.1002/ajmg.a.32688
Cocchella A, Malacarne M, Forzano F, Marciano C, Pierluigi M, Perroni L, et al. The refinement of the critical region for the 2q31.2q32.3 deletion syndrome indicates candidate genes for mental retardation and speech impairment. Am J Med Genet Part B Neuropsychiatr Genet. 2010;153:1342–6.
doi: 10.1002/ajmg.b.31107
Logan M, Tabin CJ, Duboule D, Kmita M, Tarchini B, Za J. Early developmental arrest of mammalian limbs lacking HoxA / HoxD gene function. 2005;435 June:1113–6.
Buxbaum JD, Silverman JM, Smith CJ, Kilifarski M, Reichert J, Hollander E et al. Evidence for a susceptibility gene for Autism on chromosome 2 and for genetic heterogeneity. 2001:1514–20.
Casagrande SCB, Listik C, Coelho DB, Limongi JCP, Teixeira LA, Teixeira MJ, et al. Deep brain stimulation in patients with isolated generalized Dystonia caused by PRKRA Mutation. Mov Disord Clin Pract. 2019;6:616–8.
doi: 10.1002/mdc3.12811
pubmed: 31538099
pmcid: 6749865
Tharp CA, Haywood ME, Sbaizero O, Taylor MRG, Mestroni L. The Giant Protein Titin ’ s Role in Cardiomyopathy: Genetic, Transcriptional, and Post-translational Modifications of TTN and Their Contribution to Cardiac Disease. 2019;10 November:1–8.
Ko JM. Genetic syndromes associated with congenital heart disease. Korean Circ J. 2015;45:357–61.
doi: 10.4070/kcj.2015.45.5.357
pubmed: 26413101
pmcid: 4580692
UCSC Genome Browser, Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res. 2002;12(6):996–1006.
doi: 10.1101/gr.229102